CMPX
Compass Therapeutics
$2.08
+$0.01 (+0.48%)Jul 27, 2026
Key metrics
The numbers that frame CMPX today
- Market cap
- $374.58M
- P/E (TTM)
- -5.5
- EV / FCF
- -6.2
- ROIC
- -45.1%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.61
- 52wk High
- $6.88
Growth
Revenue and earnings trend for CMPX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CMPX
Is Compass Therapeutics a good buy?
No. Compass Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Compass Therapeutics is selling at a very high price.
What is the market capitalization of CMPX?
Compass Therapeutics's market capitalization is $374.58M.
What is the P/E ratio for CMPX stock?
Compass Therapeutics's current P/E ratio is -5.5.
What is the 52-week high for CMPX stock?
The 52-week high for Compass Therapeutics is $6.88. The current close of $2.08 is 69.8% below that high.
What is the 52-week low for CMPX stock?
The 52-week low for Compass Therapeutics is $1.61. The current close of $2.08 is 29.2% above that low.
Does CMPX stock pay dividends?
Compass Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CMPX?
Compass Therapeutics's Debt / Equity ratio is 0.05.